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General approach
Technology platforms in Russia is a relatively new institutional form of cooperation between different actors in the framework of the STI policy of the Federal level. All technology platforms consist of a number of members that are interconnected by common objectives, technological areas and business perspectives. Some technology platforms are interconnected between each other by so called "universal actors" (universities or research organisations). The main instrument of Russian technology platforms establishment and development (so far) is selforganization. Transition processes within technology platforms involve practically all their members. The technology platform "Medicine of the future" which is considered as one of the most promoted is taken as an example within this case-study.
Initiative to stimulate establishment and development of technology platforms in Russia belongs to the Federal Government. The "Concept of Long Term Socio-Economic Development of Russia till 2020" adopted in October 2008 envisages establishment of technology platforms in the country and official call for proposals for establishing technology platforms has been launched in October 2010. By April 2011 the list of 27 technology platforms has been approved by the Russian Federation Government Commission on High Technology and Innovation. By October 2013 there were 34 technology platforms in Russia. All officially approved technology platforms are candidates to receive federal budget support.
What were perceptions and expectations of policy makers while discussing the idea of establishing and supporting technology platforms in Russia and taking corresponding decisions?
The main perception was that this new for Russia instrument would be a stimulus for high-tech sectors development, and thus new business demand for innovation would emerge. There was an expectation that new "actors" would be involved (first of all, universities) in innovation processes. And another expectation was that "technology mainstreams" would be activated thus increasing the capacity of technological modernization of the Russian economy.
Among 34 presently existing technology platforms two typical transition models can be identified: search model and consolidation model (Table 1) . During 2012 a number of important organizational innovations within the TPMF took place, including: First, the TPMF members have established 9 Science and Technology Councils in accordance with their research and production interests and specializations, including S&T councils on:
Self-organization of TPMF participants into a formal group (partnership).
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There are two levels of interaction of the TPMF members. Following the concept of a business ecosystem (formulated by James Moore in 1993), a technology platform can be regarded as an ecosystem, as its members in the process of transition demonstrate the following features: -both in search model and in consolidation model the basis of a technology platform transition is ensured by interacting organisations, including suppliers (R&D services of Universities and research organisations), lead producers (enterprises), competitors; -members of technology platform coevolve their capabilities through implementing their main transition instruments (Strategic Research Program and Full Cycle Complex Projects) and are embedded in the environment established by the platform activities; -member businesses tend to occupy their niche (first of all, FCCPs' technology areas) and usually are challenged by newly arriving or even existing actors. The TPMF governance structure (Fig. 3 ) which shows involvement of most of its members into interaction instruments activities is another proof of its ecosystem character. Policy paradigm -mainly networking model with elements of market and classic steering models;
Coherent policy measures in accordance with the S&T councils initiatives within interaction processes in which information is exchanged and resources consolidated;
Governance instruments -learning/consolidating process through seminars and project initiatives discussions;
Specific transition initiative and policy instrument -development of the Full cycle complex projects, envisaging implementation of the complete innovation cycle from R&D to goods and services production. In many cases this includes specific measures aimed at upgrading universities' training programs.
Public-private partnership.
Public-private partnership within TPMF is ensured through implementation of the TPMF Strategic Research Program (2012 -2020) and FCCPs that unite financial, research and administrative resources to achieve concrete results. All 34 FCCPs of the TPMF approved by the end 2013 include participation of both public research organisations, universities and business companies.
Another level of PPP of the technology platform is participation of FCCPs' consortia in implementing the Federal level initiatives (Figure 4 ). 
Policy impact analysis
Policy impact analysis of the TPMF activities has revealed 2 types of benefits so far: structural and societal ones.
Structural benefits. National innovation policy initiative to stimulate establishment and development of technology platforms in the Russian Federation has launched self-organization process of technology platforms which then transformed into coherent policy measures of the technology platforms' members based on exchange of information and consolidation of resources. These coherent policy measures allowed: 1) to institutionalize schemes of the technology platform governance (see, for example, Figure 3 -the general governance structure of the TPMF); 2) to organize efforts of the technology platforms' members into a workable scheme which allows to analyze, manage and adjust the transition process ( Figure 5 ).
As a result of structural transformations within the TPMF by the end 2013 the Steering committee of the TPMF has approved 34 FCCPs that united more than 40 companies, 40 universities and 160 research institutes.
Societal benefits of the TPMF activities are mainly ensured by formulation of advanced healthcare technology areas, responding to societal challenge to combat socially important diseases, that are going to be R&D priority areas of the TPMF until 2020 (see science and technology councils' areas above).
Business benefits of the TPMF activities will be mainly ensured by perspective benefits of companies engaged in elaboration and production of perspective pharmaceuticals and medical Risks. Some systemic risks in transition processes of the TPMF can be identified. First, the risk of rent seeking behavior of the TPMF most active members. In this connection it is important to ensure systemic vision of the transition objectives and opportunities by all members of the technology platform basing on national strategic priorities. Second, the risk of bureaucratization, when the rules of the game become formal and exclude creative behavior of the members of the technology platform. Third, the risk of shifting to supply model development and loss of demand model development. Such distortion of balance between two development models may occur due to excessive orientation to budget funding and state privileges for the technology platform members.
Future policy perspectives. The TPMF activities at present are mainly aimed at strategic research planning and carrying out R&D in the framework of FCCPs based on market and societal demand. Future successful transition will require additional efforts, mainly in upgrading university programs, training research and engineering personnel and establishing new research and engineering infrastructures.
Finally, it should be emphasized that a new approach to S&T foresight will be required. The reason is that the TPMF technologically and socially sensitive areas (medical and pharmaceutical technologies) in future may come across new ethical and ecological bottlenecks. So, new legislation initiatives will be needed and this will have to be reflected in the TPMF development strategy.
International dimension of TPMF development shall be possible through Full Cycle Complex Projects aimed at competing global challenges and socially significant diseases, introducing targeted pharmaceuticals and therapy systems, etc.
